Representative matters of Irwin IP, or its lawyers, include:
Asset Acquisitions. Conduct due diligence and asset value analyses to identify, vet, and facilitate acquisition of strategic IP assets for clients.
Biotechnology Investment Due Diligence. Advised prospective investor on the intellectual property position of a potential biotechnology portfolio company specializing in Erythropoetin (EPO) in relation to its chief competitor in the marketplace.
Enterprise Server Technology Due Diligence. Advised acquiring private equity entity on the intellectual property position and risk exposure of the target server technology company in relation to the patent portfolio of its chief competitor in the marketplace.
Fortune 200 Financial Institution. Counsel for Fortune 200 financial institution in a patent infringement matter, developing defenses in unfiled claims asserted against client’s customers.
Fortune 500 Consumer Products Distributor. Lead counsel for Fortune 500 company in connection with analyzing hundreds of patents from competitors’ patent portfolios to assess risk associated with importing and distributing a new product.
LKQ Corporation v. Major OEMs. Lead counsel for LKQ Corporation in negotiating design patent portfolio licenses with Global Fortune 50 companies.
Medical Products Developer and Distributor. Lead counsel for medical device client in connection with analyzing competitor’s patents to assess non-infringement positions and risk associated with manufacturing related product.
Ongoing Support for Multinational Corporation’s Research and Development Division. Draft and negotiate various agreements including non-disclosure agreements, material transfer agreements, professional services agreements, sponsored research agreements, and project development agreements to support multinational corporation’s research and development division.
Project Frederick. Represented an acquiring private equity entity in connection with its purchase of a regional physical therapy business and its business name and trademarks.
Project Insure. Represented an acquiring private equity entity in connection with its acquisition of a company that provides software solutions that automate the sales, service, and processing of health insurance and group benefits.
Project Katun. Handled all the intellectual property aspects of the spin-off of an international printer toner cartridge subsidiary business from its parent company.
Project Lightening. Represented an acquiring private equity entity in connection with its acquisition of a company that provides software solutions with multi-carrier, multi-line consolidated insurance billing capabilities.
Project Thoreau. Represented an acquiring corporation in connection with the potential acquisition of intellectual property relating to medical devices and pharmaceutical compositions.
Project White. Represented an acquiring private equity entity in connection with its acquisition of an equity interest and voting control in the international leading manufacturer and developer of professional and consumer tooth whitening products and dental devices.
Research Laboratory Equipment Investment Due Diligence. Oversaw a freedom to operate review and advised prospective investor on the competitive patent landscape and associated risk exposure of a potential portfolio company specializing in research laboratory equipment and services.